Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1β inhibition.

Yael Gernez Adriana A de Jesus Hanouf Alsaleem Claudia Macaubas Amitava Roy Daniel Lovell Karthik A Jagadeesh Sara Alehashemi Laura Erdman Michael Grimley Susanna Talarico Rosa Bacchetta David B Lewis Scott W Canna Ron M Laxer Elizabeth D Mellins Raphaela Goldbach-Mansky Katja G Weinacht

J Allergy Clin Immunol

Division of Stem Cell Transplantation and Regenerative Medicine, Department of Pediatrics, Stanford School of Medicine, Stanford, Calif. Electronic address:

Published: October 2019

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8425770	PMC
http://dx.doi.org/10.1016/j.jaci.2019.06.017	DOI Listing

Publication Analysis

Top Keywords

severe autoinflammation

autoinflammation patients

patients c-terminal

c-terminal variants

variants cell

cell division

division control

control protein

protein homolog

homolog cdc42

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!

Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1β inhibition.

Download full-text PDF

Publication Analysis

Top Keywords

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?